FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 337:365-372 August 7, 1997 Number 6 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Oxidizing metabolites generated at the site of coronary angioplasty can induce chain reactions that may lead to restenosis. Antioxidants may counter oxidative stress and modify neointimal formation and vascular remodeling. Experimental data and small clinical studies have suggested that antioxidants may prevent restenosis after angioplasty. In a double-blind, randomized trial, we studied whether drugs with antioxidant properties decrease the incidence and severity of restenosis after angioplasty.

Methods One month before angioplasty, 317 patients were randomly assigned to receive one of four treatments: placebo, probucol (500 mg), multivitamins (30,000 IU of beta carotene, 500 mg of vitamin C, and 700 IU of vitamin E), or both probucol and multivitamins — all given twice daily. Patients were treated for four weeks before and six months after angioplasty. Patients received an extra 1000 mg of probucol, 2000 IU of vitamin E, both probucol and vitamin E, or placebo 12 hours before angioplasty, according to their treatment assignments. Base-line and follow-up angiograms were interpreted by blinded investigators using a quantitative approach.

Results The mean (±SD) reduction in luminal diameter six months after angioplasty was 0.12±0.41 mm in the probucol group, 0.22±0.46 mm in the combined-treatment group, 0.33±0.51 mm in the multivitamin group, and 0.38±0.50 mm in the placebo group (P = 0.006 for those receiving vs. those not receiving probucol, and P = 0.70 for those receiving vs. those not receiving vitamins). Restenosis rates per segment were 20.7 percent in the probucol group, 28.9 percent in the combined-treatment group, 40.3 percent in the multivitamin group, and 38.9 percent in the placebo group (P = 0.003 for probucol vs. no probucol). The rates of repeated angioplasty were 11.2 percent, 16.2 percent, 24.4 percent, and 26.6 percent, respectively (P = 0.009 for probucol vs. no probucol).

Conclusions The antioxidant probucol is effective in reducing the rate of restenosis after balloon coronary angioplasty.

Source Information

From the Department of Medicine, Montreal Heart Institute (J.-C.T., G.C., J. Lespérance, M.B., S.D., L.B., S.N., P.G.), and the University of Montreal (J. Lambert), Montreal. Presented in part at the 69th Scientific Sessions of the American Heart Association, New Orleans, November 11, 1996.

Address reprint requests to Dr. Côté at the Research Center, Montreal Heart Institute, 5000 Bélanger St., Montreal, QC H1T 1C8, Canada.

Full Text of this Article

Related Letters:

Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty
Sirtori C. R., Franceschini G., Jay S. J., Lisi D. M., Côté G., Tardif J. C., Lespérance J.
Extract | Full Text  
N Engl J Med 1997; 337:1918-1919, Dec 25, 1997. Correspondence

This article has been cited by other articles:

• Levonen, A.-L., Vahakangas, E., Koponen, J. K., Yla-Herttuala, S. (2008). Antioxidant Gene Therapy for Cardiovascular Disease: Current Status and Future Perspectives. Circulation 117: 2142-2150 [Abstract] [Full Text]  
• Siekmeier, R., Steffen, C., Marz, W. (2007). Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations. J CARDIOVASC PHARMACOL THER 12: 265-282 [Abstract]  
• Korshunov, V. A., Schwartz, S. M., Berk, B. C. (2007). Vascular Remodeling: Hemodynamic and Biochemical Mechanisms Underlying Glagov's Phenomenon. Arterioscler. Thromb. Vasc. Bio. 27: 1722-1728 [Abstract] [Full Text]  
• Jiang, W.-J., Xu, X.-T., Jin, M., Du, B., Dong, K.-H., Dai, J.-P. (2007). Apollo Stent for Symptomatic Atherosclerotic Intracranial Stenosis: Study Results. Am. J. Neuroradiol. 28: 830-834 [Abstract] [Full Text]  
• Wierzbicki, A. S (2007). Voodoo medicine -- cardiovascular trials jinxed in New Orleans: Dr Anthony Wierzbicki discusses highlights of the 56th Annual Scientific Session of American College of Cardiology held at Morial Conventions Centre in New Orleans March 24th--27th, 2007. British Journal of Diabetes & Vascular Disease 7: 142-144  
• Tardif, J.-C., Gregoire, J., L'Allier, P. L., Ibrahim, R., Lesperance, J., Heinonen, T. M., Kouz, S., Berry, C., Basser, R., Lavoie, M.-A., Guertin, M.-C., Rodes-Cabau, J., for the Effect of rHDL on Atherosclerosis-Safety a, (2007). Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis: A Randomized Controlled Trial. JAMA 297: 1675-1682 [Abstract] [Full Text]  
• Stocker, R., Perrella, M. A. (2006). Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases?. Circulation 114: 2178-2189 [Full Text]  
• Bleys, J., Miller, E. R III, Pastor-Barriuso, R., Appel, L. J, Guallar, E. (2006). Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials.. Am. J. Clin. Nutr. 84: 880-887 [Abstract] [Full Text]  
• Feletou, M., Vanhoutte, P. M. (2006). Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am. J. Physiol. Heart Circ. Physiol. 291: H985-H1002 [Abstract] [Full Text]  
• Fisher, M., Lees, K., Spence, J. D. (2006). Nutrition and Stroke Prevention. Stroke 37: 2430-2435 [Abstract] [Full Text]  
• Heinecke, J. W. (2006). Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?. J. Exp. Med. 203: 813-816 [Abstract] [Full Text]  
• Wu, B. J., Kathir, K., Witting, P. K., Beck, K., Choy, K., Li, C., Croft, K. D., Mori, T. A., Tanous, D., Adams, M. R., Lau, A. K., Stocker, R. (2006). Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J. Exp. Med. 203: 1117-1127 [Abstract] [Full Text]  
• Franks, A. M, Gardner, S. F (2006). AGI-1067: A Novel Vascular Protectant for Prevention of Restenosis. The Annals of Pharmacotherapy 40: 66-73 [Abstract] [Full Text]  
• Hinagata, J.-i., Kakutani, M., Fujii, T., Naruko, T., Inoue, N., Fujita, Y., Mehta, J. L., Ueda, M., Sawamura, T. (2006). Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovasc Res 69: 263-271 [Abstract] [Full Text]  
• Koh, K. K., Han, S. H., Shin, M.-S., Ahn, J. Y., Lee, Y., Shin, E. K. (2005). Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study. Eur Heart J 26: 1362-1368 [Abstract] [Full Text]  
• Goligorsky, M. S. (2005). Endothelial cell dysfunction: can't live with it, how to live without it. Am. J. Physiol. Renal Physiol. 288: F871-F880 [Abstract] [Full Text]  
• Witting, P. K., Wu, B. J., Raftery, M., Southwell-Keely, P., Stocker, R. (2005). Probucol Protects against Hypochlorite-induced Endothelial Dysfunction: IDENTIFICATION OF A NOVEL PATHWAY OF PROBUCOL OXIDATION TO A BIOLOGICALLY ACTIVE INTERMEDIATE. J. Biol. Chem. 280: 15612-15618 [Abstract] [Full Text]  
• Chen, J.-W., Lin, F.-Y., Chen, Y.-H., Wu, T.-C., Chen, Y.-L., Lin, S.-J. (2004). Carvedilol Inhibits Tumor Necrosis Factor-{alpha}-Induced Endothelial Transcription Factor Activation, Adhesion Molecule Expression, and Adhesiveness to Human Mononuclear Cells. Arterioscler. Thromb. Vasc. Bio. 24: 2075-2081 [Abstract] [Full Text]  
• Stocker, R., Keaney, J. F. Jr. (2004). Role of Oxidative Modifications in Atherosclerosis. Physiol. Rev. 84: 1381-1478 [Abstract] [Full Text]  
• Deng, Y.-M., Wu, B. J., Witting, P. K., Stocker, R. (2004). Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1. Circulation 110: 1855-1860 [Abstract] [Full Text]  
• Chen, Z., Keaney, J. F. Jr., Schulz, E., Levison, B., Shan, L., Sakuma, M., Zhang, X., Shi, C., Hazen, S. L., Simon, D. I. (2004). Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury. Proc. Natl. Acad. Sci. USA 101: 13014-13019 [Abstract] [Full Text]  
• Davignon, J., Ganz, P. (2004). Role of Endothelial Dysfunction in Atherosclerosis. Circulation 109: III-27-III-32 [Abstract] [Full Text]  
• Chyu, K.-Y., Babbidge, S. M., Zhao, X., Dandillaya, R., Rietveld, A. G., Yano, J., Dimayuga, P., Cercek, B., Shah, P. K. (2004). Differential Effects of Green Tea-Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E-Null Mice. Circulation 109: 2448-2453 [Abstract] [Full Text]  
• Do, Y. S., Kao, E. Y., Ganaha, F., Minamiguchi, H., Sugimoto, K., Lee, J., Elkins, C. J., Amabile, P. G., Kuo, M. D., Wang, D. S., Waugh, J. M., Dake, M. D. (2004). In-Stent Restenosis Limitation with Stent-based Controlled-Release Nitric Oxide: Initial Results in Rabbits. Radiology 230: 377-382 [Abstract] [Full Text]  
• Leite, P. F., Danilovic, A., Moriel, P., Dantas, K., Marklund, S., Dantas, A. P. V., Laurindo, F. R.M. (2003). Sustained Decrease in Superoxide Dismutase Activity Underlies Constrictive Remodeling After Balloon Injury in Rabbits. Arterioscler. Thromb. Vasc. Bio. 23: 2197-2202 [Abstract] [Full Text]  
• Koh, K. K., Ahn, J. Y., Jin, D. K., Yoon, B.-K., Kim, H. S., Kim, D. S., Kang, W. C., Han, S. H., Choi, I. S., Shin, E. K. (2003). Significant Differential Effects of Hormone Therapy or Tibolone on Markers of Cardiovascular Disease in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Arterioscler. Thromb. Vasc. Bio. 23: 1889-1894 [Abstract] [Full Text]  
• Dee, S. V., Samady, H. (2003). Evolving Strategies for the Prevention and Treatment of Coronary Restenosis. SEMIN CARDIOTHORAC VASC ANESTH 7: 281-293 [Abstract]  
• Cipollone, F, Fazia, M, Iezzi, A, Pini, B, Costantini, F, De Cesare, D, Paloscia, L, Materazzo, G, D'Annunzio, E, Bucciarelli, T, Vecchiet, J, Chiarelli, F, Cuccurullo, F, Mezzetti, A (2003). High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. Heart 89: 773-779 [Abstract] [Full Text]  
• Morris, C. D., Carson, S. (2003). Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 139: 56-70 [Abstract] [Full Text]  
• Braun, A., Zhang, S., Miettinen, H. E., Ebrahim, S., Holm, T. M., Vasile, E., Post, M. J., Yoerger, D. M., Picard, M. H., Krieger, J. L., Andrews, N. C., Simons, M., Krieger, M. (2003). Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc. Natl. Acad. Sci. USA 100: 7283-7288 [Abstract] [Full Text]  
• Lau, A. K., Leichtweis, S. B., Hume, P., Mashima, R., Hou, J. Y., Chaufour, X., Wilkinson, B., Hunt, N. H., Celermajer, D. S., Stocker, R. (2003). Probucol Promotes Functional Reendothelialization in Balloon-Injured Rabbit Aortas. Circulation 107: 2031-2036 [Abstract] [Full Text]  
• Gotto, A. M. Jr (2003). Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol 41: 1205-1210 [Abstract] [Full Text]  
• Urban, P., Serruys, P., Baumgart, D., Colombo, A., Silber, S., Eeckhout, E., Gershlick, A., Wegscheider, K., Verhees, L., Bonan, R., For the RENO investigators, (2003). A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J 24: 604-612 [Abstract] [Full Text]  
• Tardif, J.-C., Gregoire, J., Schwartz, L., Title, L., Laramee, L., Reeves, F., Lesperance, J., Bourassa, M. G., L'Allier, P. L., Glass, M., Lambert, J., Guertin, M.-C., for the Canadian Antioxidant Restenosis Trial (CAR, (2003). Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions. Circulation 107: 552-558 [Abstract] [Full Text]  
• Waters, D. D., Alderman, E. L., Hsia, J., Howard, B. V., Cobb, F. R., Rogers, W. J., Ouyang, P., Thompson, P., Tardif, J. C., Higginson, L., Bittner, V., Steffes, M., Gordon, D. J., Proschan, M., Younes, N., Verter, J. I. (2002). Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women: A Randomized Controlled Trial. JAMA 288: 2432-2440 [Abstract] [Full Text]  
• Fontana, L., Giagulli, C., Cominacini, L., Pasini, A. F., Minuz, P., Lechi, A., Sala, A., Laudanna, C. (2002). {beta}2 Integrin-Dependent Neutrophil Adhesion Induced by Minimally Modified Low-Density Lipoproteins Is Mainly Mediated by F2-Isoprostanes. Circulation 106: 2434-2441 [Abstract] [Full Text]  
• Laukkanen, M. O., Kivela, A., Rissanen, T., Rutanen, J., Karkkainen, M. K., Leppanen, O., Brasen, J. H., Yla-Herttuala, S. (2002). Adenovirus-Mediated Extracellular Superoxide Dismutase Gene Therapy Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta. Circulation 106: 1999-2003 [Abstract] [Full Text]  
• Komai, N., Morishita, R., Yamada, S., Oishi, M., Iguchi, S., Aoki, M., Sasaki, M., Sakurabayashi, I., Higaki, J., Ogihara, T. (2002). Mitogenic Activity of Oxidized Lipoprotein (a) on Human Vascular Smooth Muscle Cells. Hypertension 40: 310-314 [Abstract] [Full Text]  
• Theilmeier, G., Quarck, R., Verhamme, P., Bochaton-Piallat, M.-L., Lox, M., Bernar, H., Janssens, S., Kockx, M., Gabbiani, G., Collen, D., Holvoet, P. (2002). Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty. Cardiovasc Res 55: 385-395 [Abstract] [Full Text]  
• Fairfield, K. M., Fletcher, R. H. (2002). Vitamins for Chronic Disease Prevention in Adults: Scientific Review. JAMA 287: 3116-3126 [Abstract] [Full Text]  
• Mori, E., Komori, K., Yamaoka, T., Tanii, M., Kataoka, C., Takeshita, A., Usui, M., Egashira, K., Sugimachi, K. (2002). Essential Role of Monocyte Chemoattractant Protein-1 in Development of Restenotic Changes (Neointimal Hyperplasia and Constrictive Remodeling) After Balloon Angioplasty in Hypercholesterolemic Rabbits. Circulation 105: 2905-2910 [Abstract] [Full Text]  
• Schnyder, G., Roffi, M., Flammer, Y., Pin, R., Hess, O.M. (2002). Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty. Eur Heart J 23: 726-733 [Abstract] [Full Text]  
• Pataki, T., Bak, I., Kovacs, P., Bagchi, D., Das, D. K, Tosaki, A. (2002). Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am. J. Clin. Nutr. 75: 894-899 [Abstract] [Full Text]  
• Violi, F., Micheletta, F., Iuliano, L. (2002). Antioxidants and atherosclerosis. Eur Heart J Suppl 4: B17-B21 [Abstract]  
• Sawayama, Y., Shimizu, C., Maeda, N., Tatsukawa, M., Kinukawa, N., Koyanagi, S., Kashiwagi, S., Hayashi, J. (2002). Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia: Fukuoka atherosclerosis trial (FAST). J Am Coll Cardiol 39: 610-616 [Abstract] [Full Text]  
• Lowe, H. C., Oesterle, S. N., Khachigian, L. M. (2002). Coronary in-stent restenosis: Current status and future strategies. J Am Coll Cardiol 39: 183-193 [Abstract] [Full Text]  
• Park, K. S., Kim, J. H., Kim, M. S., Kim, J. M., Kim, S. K., Choi, J. Y., Chung, M. H., Han, B., Kim, S. Y., Lee, H. K. (2001). Effects of Insulin and Antioxidant on Plasma 8-Hydroxyguanine and Tissue 8-Hydroxydeoxyguanosine in Streptozotocin-Induced Diabetic Rats. Diabetes 50: 2837-2841 [Abstract] [Full Text]  
• Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F. R., Meier, B., Turi, Z. G., Hess, O. M. (2001). Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels. NEJM 345: 1593-1600 [Abstract] [Full Text]  
• Brasen, J. H., Kivela, A., Roser, K., Rissanen, T. T., Niemi, M., Luft, F. C., Donath, K., Yla-Herttuala, S. (2001). Angiogenesis, Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor-BB Expression, Iron Deposition, and Oxidation-Specific Epitopes in Stented Human Coronary Arteries. Arterioscler. Thromb. Vasc. Bio. 21: 1720-1726 [Abstract] [Full Text]  
• Pettersen, R. J., Muna, Z. A., Kuiper, K. K.J., Svendsen, E., Muller, F., Aukrust, P., Berge, R. K., Erik Nordrehaug, J. (2001). Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig. Cardiovasc Res 52: 306-313 [Abstract] [Full Text]  
• Rosenthal, E. A., Bohlmeyer, T. J., Monnet, E., MacPhail, C., Robertson, A. D., Horwitz, M. A., Burchenal, J. E.B., Horwitz, L. D. (2001). An Iron-Binding Exochelin Prevents Restenosis Due to Coronary Artery Balloon Injury in a Porcine Model. Circulation 104: 2222-2227 [Abstract] [Full Text]  
• Nakayama, M., Takahashi, K., Komaru, T., Fukuchi, M., Shioiri, H., Sato, K.-i., Kitamuro, T., Shirato, K., Yamaguchi, T., Suematsu, M., Shibahara, S. (2001). Increased Expression of Heme Oxygenase-1 and Bilirubin Accumulation in Foam Cells of Rabbit Atherosclerotic Lesions. Arterioscler. Thromb. Vasc. Bio. 21: 1373-1377 [Abstract] [Full Text]  
• Ward, M. R., Kanellakis, P., Ramsey, D., Funder, J., Bobik, A. (2001). Eplerenone Suppresses Constrictive Remodeling and Collagen Accumulation After Angioplasty in Porcine Coronary Arteries. Circulation 104: 467-472 [Abstract] [Full Text]  
• Aoki, M., Nata, T., Morishita, R., Matsushita, H., Nakagami, H., Yamamoto, K., Yamazaki, K., Nakabayashi, M., Ogihara, T., Kaneda, Y. (2001). Endothelial Apoptosis Induced by Oxidative Stress Through Activation of NF-{kappa}B: Antiapoptotic Effect of Antioxidant Agents on Endothelial Cells. Hypertension 38: 48-55 [Abstract] [Full Text]  
• Smith, S. C. Jr, Dove, J. T., Jacobs, A. K., Ward Kennedy, J., Kereiakes, D., Kern, M. J., Kuntz, R. E., Popma, J. J., Schaff, H. V., Williams, D. O., Gibbons, R. J., Alpert, J. P., Eagle, K. A., Faxon, D. P., Fuster, V., Gardner, T. J., Gregoratos, G., Russell, R. O., Smith, S. C. Jr (2001). ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 37: 2239-2239 [Full Text]  
• Shi, Y., Niculescu, R., Wang, D., Patel, S., Davenpeck, K. L., Zalewski, A. (2001). Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury. Arterioscler. Thromb. Vasc. Bio. 21: 739-745 [Abstract] [Full Text]  
• Tomimoto, S., Tsujita, M., Okazaki, M., Usui, S., Tada, T., Fukutomi, T., Ito, S., Itoh, M., Yokoyama, S. (2001). Effect of Probucol in Lecithin-Cholesterol Acyltransferase-Deficient Mice : Inhibition of 2 Independent Cellular Cholesterol-Releasing Pathways In Vivo. Arterioscler. Thromb. Vasc. Bio. 21: 394-400 [Abstract] [Full Text]  
• Tardif, J.-C., Gregoire, J., Serruys, P. W., Foley, D. P., Hofling, B., Puel, J., Glogar, H. D., Seabra-Gomes, R., Goicolea, J., Coste, P., Rutsch, W., Katus, H., Bonnier, H., Wijns, W., Betriu, A., Hauf-Zachariou, U., Montauban van Swijndregt, E., Melkert, R., Simon, R. (2001). Antioxidants and Prevention of Restenosis After Directional Coronary Atherectomy Response. Circulation 103 : e51-e52 [Full Text]  
• Fontana, L., Giagulli, C., Minuz, P., Lechi, A., Laudanna, C. (2001). 8-Iso-PGF2{{alpha}} Induces {beta}2-Integrin-Mediated Rapid Adhesion of Human Polymorphonuclear Neutrophils : A Link Between Oxidative Stress and Ischemia/Reperfusion Injury. Arterioscler. Thromb. Vasc. Bio. 21: 55-60 [Abstract] [Full Text]  
• Chai, Y.-C., Binion, D. G., Chisolm, G. M. (2000). Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation. Am. J. Physiol. Heart Circ. Physiol. 279: H1830-H1838 [Abstract] [Full Text]  
• Jianhua Zhu, , Danchen Gao, (2000). Losartan reduces collagen content and intimal thickening of iliac arteries after balloon injury in rabbits. Journal of Renin-Angiotensin-Aldosterone System 1: 278-282 [Abstract]  
• Azevedo, L. C.P., Pedro, M. d. A., Souza, L. C., de Souza, H. P., Janiszewski, M., da Luz, P. L., Laurindo, F. R.M. (2000). Oxidative stress as a signaling mechanism of the vascular response to injury: The redox hypothesis of restenosis. Cardiovasc Res 47: 436-445 [Abstract] [Full Text]  
• Altavilla, D., Deodato, B., Campo, G. M., Arlotta, M., Miano, M., Squadrito, G., Saitta, A., Cucinotta, D., Ceccarelli, S., Ferlito, M., Tringali, M., Minutoli, L., Caputi, A. P., Squadrito, F. (2000). IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-{kappa}B and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res 47: 515-528 [Abstract] [Full Text]  
• Witting, P. K., Pettersson, K., Letters, J., Stocker, R. (2000). Site-Specific Antiatherogenic Effect of Probucol in Apolipoprotein E-Deficient Mice. Arterioscler. Thromb. Vasc. Bio. 20 : e26-e33 [Abstract] [Full Text]  
• Waugh, J. M., Li-Hawkins, J., Yuksel, E., Kuo, M. D., Cifra, P. N., Hilfiker, P. R., Geske, R., Chawla, M., Thomas, J., Shenaq, S. M., Dake, M. D., Woo, S. L. C. (2000). Thrombomodulin Overexpression to Limit Neointima Formation. Circulation 102: 332-337 [Abstract] [Full Text]  
• Meerkin, D., Tardif, J.-C., Bertrand, O. F., Vincent, J., Harel, F., Bonan, R. (2000). The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections. J Am Coll Cardiol 36: 59-64 [Abstract] [Full Text]  
• Serruys, P. W., Foley, D. P., Hofling, B., Puel, J., Glogar, H. D., Seabra-Gomes, R., Goicolea, J., Coste, P., Rutsch, W., Katus, H., Bonnier, H., Wijns, W., Betriu, A., Hauf-Zachariou, U., van Swijndregt, E. M., Melkert, R., Simon, R. (2000). Carvedilol for Prevention of Restenosis After Directional Coronary Atherectomy : Final Results of the European Carvedilol Atherectomy Restenosis (EUROCARE) Trial. Circulation 101: 1512-1518 [Abstract] [Full Text]  
• Connors III, J. J., Seidenwurm, D., Wojak, J. C., Hurst, R. W., Jensen, M. E., Wallace, R., Tomsick, T., Barr, J., Kerber, C., Russell, E., Nesbit, G. M., Fox, A. J., Tsai, F. Y. (2000). Treatment of Atherosclerotic Disease at the Cervical Carotid Bifurcation: Current Status and Review of the Literature. Am. J. Neuroradiol. 21: 444-450 [Full Text]  
• Schroepfer, G. J. Jr. (2000). Oxysterols: Modulators of Cholesterol Metabolism and Other Processes. Physiol. Rev. 80: 361-554 [Abstract] [Full Text]  
• Feng, A.-N., Chen, Y.-L., Chen, Y.-T., Ding, Y.-Z., Lin, S.-J. (1999). Red Wine Inhibits Monocyte Chemotactic Protein-1 Expression and Modestly Reduces Neointimal Hyperplasia After Balloon Injury in Cholesterol-Fed Rabbits. Circulation 100: 2254-2259 [Abstract] [Full Text]  
• Mezzetti, A., Guglielmi, M. D., Pierdomenico, S. D., Costantini, F., Cipollone, F., De Cesare, D., Bucciarelli, T., Ucchino, S., Chiarelli, F., Cuccurullo, F., Romano, F. (1999). Increased Systemic Oxidative Stress After Elective Endarterectomy : Relation to Vascular Healing and Remodeling. Arterioscler. Thromb. Vasc. Bio. 19: 2659-2665 [Abstract] [Full Text]  
• Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., O'Connor, G. T., Orszulak, T. A., Rieselbach, R. E., Winters, W. L., Yusuf, S., Gibbons, R. J., Alpert, J. S., Eagle, K. A., Gardner, T. J., Garson, A. Jr., Gregoratos, G., Russell, R. O., Smith, S. C. Jr. (1999). ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 34: 1262-1347 [Full Text]  
• Hollis, S., Campbell, F. (1999). What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319: 670-674 [Abstract] [Full Text]  
• Harjai, K. J. (1999). Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen. ANN INTERN MED 131: 376-386 [Abstract] [Full Text]  
• Yusuf, S. (1999). Randomised controlled trials in cardiovascular medicine: past achievements, future challenges. BMJ 319: 564-568 [Full Text]  
• Brar, S. S., Kennedy, T. P., Whorton, A. R., Murphy, T. M., Chitano, P., Hoidal, J. R. (1999). Requirement for Reactive Oxygen Species in Serum-induced and Platelet-derived Growth Factor-induced Growth of Airway Smooth Muscle. J. Biol. Chem. 274: 20017-20026 [Abstract] [Full Text]  
• Bilder, G., Wentz, T., Leadley, R., Amin, D., Byan, L., O'Conner, B., Needle, S., Galczenski, H., Bostwick, J., Kasiewski, C., Myers, M., Spada, A., Merkel, L., Ly, C., Persons, P., Page, K., Perrone, M., Dunwiddie, C. (1999). Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A. Circulation 99: 3292-3299 [Abstract] [Full Text]  
• Johansen, O., Brekke, M., Seljeflot, I., Abdelnoor, M., Arnesen, H. (1999). n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. J Am Coll Cardiol 33: 1619-1626 [Abstract] [Full Text]  
• Rinninger, F., Wang, N., Ramakrishnan, R., Jiang, X. C., Tall, A. R. (1999). Probucol Enhances Selective Uptake of HDL-Associated Cholesteryl Esters In Vitro by a Scavenger Receptor B-I–Dependent Mechanism. Arterioscler. Thromb. Vasc. Bio. 19: 1325-1332 [Abstract] [Full Text]  
• Moghadasian, M. H., McManus, B. M., Godin, D. V., Rodrigues, B., Frohlich, J. J. (1999). Proatherogenic and Antiatherogenic Effects of Probucol and Phytosterols in Apolipoprotein E–Deficient Mice : Possible Mechanisms of Action. Circulation 99: 1733-1739 [Abstract] [Full Text]  
• Tribble, D. L. (1999). Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and ß-Carotene : A Statement for Healthcare Professionals From the American Heart Association. Circulation 99: 591-595 [Full Text]  
• Pollman, M. J., Hall, J. L., Gibbons, G. H. (1999). Determinants of Vascular Smooth Muscle Cell Apoptosis After Balloon Angioplasty Injury : Influence of Redox State and Cell Phenotype. Circ. Res. 84: 113-121 [Abstract] [Full Text]  
• Cote, G., Tardif, J.-C., Lesperance, J., Lambert, J., Bourassa, M., Bonan, R., Gosselin, G., Joyal, M., Tanguay, J.-F., Nattel, S., Gallo, R., Crepeau, J. (1999). Effects of Probucol on Vascular Remodeling After Coronary Angioplasty. Circulation 99: 30-35 [Abstract] [Full Text]  
• Klugherz, B. D., Meneveau, N., Chen, W., Wade-Whittaker, F., Papandreou, G., Levy, R., Wilensky, R. L. (1999). Sustained Intramural Retention and Regional Redistribution Following Local Vascular Delivery of Polylactic-Coglycolic Acid and Liposomal Nanoparticulate Formulations Containing Probucol. J CARDIOVASC PHARMACOL THER 4: 167-174 [Abstract]  
• Heckenkamp, J., Lamuraglia, G. M. (1999). Intimal Hyperplasia, Arterial Remodeling, and Restenosis: An Overview. PERSPECT VASC SURG ENDOVASC THER 11: 71-94 [Abstract]  
• Loop, F. D. (1998). Coronary artery surgery: the end of the beginning. Eur. J. Cardiothorac. Surg. 14: 554-571 [Abstract] [Full Text]  
• Tröger, U., Meyer, F. P (1998). Personal paper: Validity of advertising claims for multivitamin preparation Vitacor 20/90 on the internet. BMJ 317: 1069-1071 [Full Text]  
• Janiszewski, M., Pasqualucci, C. A, Souza, L. C, Pileggi, F., da Luz, P. L, M. Laurindo, F. R (1998). Oxidized thiols markedly amplify the vascular response to balloon injury in rabbits through a redox active metal-dependent pathway. Cardiovasc Res 39: 327-338 [Abstract] [Full Text]  
• Speir, E., Yu, Z.-X., Ferrans, V. J., Huang, E.-S., Epstein, S. E. (1998). Aspirin Attenuates Cytomegalovirus Infectivity and Gene Expression Mediated by Cyclooxygenase-2 in Coronary Artery Smooth Muscle Cells. Circ. Res. 83: 210-216 [Abstract] [Full Text]  
• Lafont, A., Faxon, D. (1998). Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?. Cardiovasc Res 39: 50-59 [Full Text]  
• DeYoung, M. B., Dichek, D. A. (1998). Gene Therapy for Restenosis : Are We Ready?. Circ. Res. 82: 306-313 [Abstract] [Full Text]  
• Edelman, E. R. (1998). Vessel Size, Antioxidants, and Restenosis : Never Too Small, Not Too Little, but Often Too Late. Circulation 97: 416-420 [Full Text]  
• Rodes, J., Cote, G., Lesperance, J., Bourassa, M. G., Doucet, S., Bilodeau, L., Bertrand, O. F., Harel, F., Gallo, R., Tardif, J.-C. (1998). Prevention of Restenosis After Angioplasty in Small Coronary Arteries With Probucol. Circulation 97: 429-436 [Abstract] [Full Text]  
• Sirtori, C. R., Franceschini, G., Jay, S. J., Lisi, D. M., Cote, G., Tardif, J. C., Lesperance, J. (1997). Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty. NEJM 337: 1918-1919 [Full Text]  
• Braunwald, E. (1997). Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities. NEJM 337: 1360-1369 [Full Text]  
• (1997). Probucol Prevents Restenosis. Journal Watch Cardiology 1997: 2-2 [Full Text]